ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag biomarkers stem cells bioinformatics cancer

obituary, obituaries, roundup, end of the year, COVID-19, SARS-CoV-2, pandemic, coronavirus, immunology, genetics & genomics, cell & molecular biology, HIV
Those We Lost in 2020
Amanda Heidt | Dec 18, 2020 | 7 min read
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
The Scientist Staff | Mar 28, 2024
2017 Top 10 Innovations
The Scientist | Dec 1, 2017 | 10+ min read
From single-cell analysis to whole-genome sequencing, this year's best new products shine on many levels.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
The New Face of Cancer
Kelly Rae Chi | Jan 13, 2010 | 5 min read
The New Face of Cancer An unusual institute is applying the newest concepts in life sciences—stem cell therapies, personalized medicine—to one of the oldest diseases. By Kelly Rae Chi The Ontario Institute for Cancer Research (OICR) does not take a typical approach to the disease. Many cancer researchers toil away individually, only sharing their results after peer review. But for cancer researchers to receive some of the roughly $39 million the
Macrophages Play a Double Role in Cancer
Amanda B. Keener | Apr 1, 2018 | 10+ min read
Macrophages play numerous roles within tumors, leaving cancer researchers with a choice: eliminate the cells or recruit them.
High-Throughput Epigenetics Analyses
Jyoti Madhusoodanan | Jan 1, 2018 | 7 min read
Emerging technologies help researchers draw mechanistic links between metabolism and epigenetic modification of DNA.
Integrating Multiple -Omics in Individual Cells
Sandeep Ravindran | Oct 1, 2018 | 8 min read
New techniques combine DNA, RNA, and protein information from single cells.
Heading for the BIG Time
Kenneth Buetow | Apr 1, 2008 | 9 min read
Heading for the BIG Time The NCI's bioinformatics network,caBIG, integrates cancer data fromacross the United states.Its goal: to speed the transition from research to therapy By Kenneth Buetow Artwork by Brendan Monroe Related Articles A sampling of how you can use caBIG caBIG in Action I was at the National Cancer Institute's (NCI) Intramural Program Scientific Retreat this past January listening to a plenary presentation by Cambridge Un
Diagnosing Cancer: A Genomics and Proteomics Approach
Tom Hollon | Sep 21, 2003 | 7 min read
In 1996, Jeff Trent and colleagues published the first paper describing DNA microarrays as tools for pinpointing gene variants underlying various tumor properties.1 Now, as president and scientific director of Translational Genomics Research Institute (TGEN), in Phoenix, Trent is using microarrays to look for gene expression patterns that can be applied to developing diagnostics. The role of microarrays, Trent says, "will be on the discovery side. Testing all 30,000 genes against a diagnosti

Run a Search

ADVERTISEMENT